| Literature DB >> 31267993 |
Prashant Gupta1, Jawahar Singh1, Ananya Mahapatra1, Pratap Sharan1.
Abstract
Tacrolimus is one of the mainstays for post-transplant immunosuppression. A variety of neuropsychiatric adverse effects have been reported above the levels of its therapeutic use. Manic symptoms associated with its use have been rarely reported. We report possibly the first such case in a child post-renal transplantation and discuss the potential neuro-immunological basis of these symptoms.Entities:
Mesh:
Substances:
Year: 2018 PMID: 31267993 DOI: 10.4103/0970-258X.261183
Source DB: PubMed Journal: Natl Med J India ISSN: 0970-258X Impact factor: 0.537